Does Rallies show 13F holders for OM?

Yes. Rallies tracks hedge fund and 13F ownership data for OM, including fund names, share counts, latest tracked quarter, and position changes when available.

Is OM research on Rallies investment advice?

No. Rallies provides research, data, and educational context for OM. It does not provide personalized investment advice.

OM (Outset Medical, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Outset Medical, Inc. Common Stock (OM) is a publicly traded Healthcare sector company. As of May 21, 2026, OM trades at $4.38 with a market cap of $68.96M and a P/E ratio of -1.04. OM moved +13.73% today. Year to date, OM is +15.26%; over the trailing twelve months it is -77.55%. Its 52-week range spans $3.00 to $25.35. Analyst consensus is strong buy with an average price target of $9.50. Rallies surfaces OM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns OM stock?

Hedge funds tracked by Rallies that own OM include Bridgewater Associates. The latest tracked quarter is Sep 30, 2023. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Outset Medical, Inc. Common Stock.

OM Key Metrics

Key financial metrics for OM
Metric	Value
Price	$4.38
Market Cap	$68.96M
P/E Ratio	-1.04
EPS	$-4.07
Dividend Yield	0.00%
52-Week High	$25.35
52-Week Low	$3.00
Volume	0
Avg Volume	0
Revenue (TTM)	$117.59M
Net Income	$-74.85M
Gross Margin	40.64%

Top Hedge Funds Holding OM

Bridgewater Associates holds 58.57K shares of OM, changed +0.00% as of Sep 30, 2023.

Latest OM News

Outset Medical Q1 Revenue Drops 6% to $27.9M, Gross Margin Rises to 43.4% — May 7, 2026
Analysts Project $28.9M Q1 Revenue for Outset Medical, Price Target of $9.00 — May 6, 2026
Outset Medical appoints Derick Elliott EVP to expand Tablo in nearly 1,000 facilities — Apr 6, 2026
Outset Medical Q4 Margins Jump 600bps, Price Targets Cut to $12 and $15 — Feb 20, 2026
Stifel Cuts Outset Medical Price Target to $8, Keeps Buy Rating — Feb 9, 2026

Recent OM Insider Trades

Trigg Leslie sold 3.44K (~$12.75K) on May 15, 2026.
Nash Marc sold 1.58K (~$5.85K) on May 15, 2026.
Brottem John L. sold 2.64K (~$9.76K) on May 15, 2026.

OM Analyst Consensus

4 analysts cover OM: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.50.

Common questions about OM

Who owns OM stock?: Hedge funds tracked by Rallies that own OM include Bridgewater Associates. The latest tracked quarter is Sep 30, 2023. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Outset Medical, Inc. Common Stock.
Does Rallies show 13F holders for OM?: Yes. Rallies tracks hedge fund and 13F ownership data for OM, including fund names, share counts, latest tracked quarter, and position changes when available.
Is OM research on Rallies investment advice?: No. Rallies provides research, data, and educational context for OM. It does not provide personalized investment advice.